Business Wire

ADVA

11.11.2021 09:02:09 CET | Business Wire | Press release

Share
ADVA launches new traffic grooming solution to reduce metro costs

ADVA (FSE: ADV) today launched its FSP 3000 OpenFabric1200™ solution to help network operators significantly reduce metro costs. The OTN-based technology enables client services to be groomed into 400Gbit/s wavelengths, maximizing fiber capacity and supporting cost-efficient coherent networks. The latest member of the FSP 3000 OpenFabric Series combines open 400Gbit/s pluggable coherent technology with OTN switching on a blade, increasing wavelength efficiency. The open switchponder card can be added to any network without requiring additional adaptors. Specifically engineered for the 400Gbit/s era, the ADVA FSP 3000 OpenFabric1200 features 1200Gbit/s interface capacity and supports Ethernet and OTN services from 10Gbit/s to 400Gbit/s.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211111005220/en/

“The strain on today’s transport infrastructure is growing like never before. Today’s operators need new solutions that can meet rapidly rising data demand while also driving down costs. That’s why we’ve developed our FSP 3000 OpenFabric1200 . It offers a simple way to dramatically increase fiber efficiency by supporting lower-speed service grooming at the network edge. By deploying OpenFabric1200 in ring or hub-and-spoke topologies, operators can significantly reduce switching and cross-connect requirements in the core,” said Christoph Glingener, CTO, ADVA. “What’s more, our open Terabit-scale switchponder solution can be easily added to any network.”

The new technology is part of the ADVA FSP 3000 OpenFabric Series, a family of switchponders built for maximum openness, flexibility and scale. The OpenFabric1200 offers OTN switching with the benefits of open CFP2 pluggable coherent interfaces. With Terabit capacity, the new card is the ideal tool for leveraging more value from deployed metro infrastructure and upgrading legacy networks to the latest coherent pluggable technology. The FSP 3000 OpenFabric1200 can work in multiple operation modes: ADM on a blade, DWDM muxponders, or OTN cross-connect. What’s more, thanks to its open design, client services can be connected directly or via standard OTN-based transponders without the need for any adapters.

“Our FSP 3000 OpenFabric1200 will be a key tool in tackling skyrocketing bandwidth demand while supporting existing low-speed services. The technology takes our OpenFabric concept to the next level, enabling traffic grooming at the edge where it’s most efficient and delivering 1.2Tbit/s interface capacity. It offers the power to adapt to changing traffic demands without a hardware upgrade while simplifying operations and enabling network operators to scale as and when needed,” commented Cornelius Fürst, director, product line management, ADVA. “Our FSP 3000 OpenFabric1200 is the flexible OTN solution that’s about to switch things up. For metro network operators, our new switchponder opens the door to the benefits of disaggregated environments and the latest pluggable coherent 400Gbit/s technology.”

Watch this video for more information on the FSP 3000 OpenFabric1200™: https://youtu.be/ti101PI1fxw .

Further details are also available in these slides: https://adva.li/fsp-3000-openfabric1200-slides .

A supporting solution brief can be downloaded here: https://adva.li/fsp-3000-openfabric-series-solution-brief .


About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com .

Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com

Social Media:

https://www.facebook.com/ADVAOpticalNetworking

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 11:18:00 CEST | Press release

Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0

FPT Launches Flezi Foundry™, Advancing AI-Augmented Delivery for Global Enterprises22.5.2026 10:11:00 CEST | Press release

Global IT corporation FPT announced the launch of Flezi Foundry™ (FPT Digital Foundry™), an AI-augmented delivery platform for software development and IT operations. Built around a governed Service-as-a-Software model, the platform combines autonomous AI agents, human expert oversight, secure infrastructure, and outcome-based delivery mechanisms to help enterprises modernize technology delivery as AI agents become part of software engineering and IT operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521235556/en/ Flezi Foundry applies Agentic Engineering, a structured delivery approach for software development and IT operations. The model brings AI agents into delivery workflows with human supervision, governance, transparency, and performance measurement built into the process. Flezi Foundry operates through two service modes: Agentic Development Lifecycle (ADLC) supports software development by using specialize

Boomi Named One of The Sunday Times Best Places to Work 202622.5.2026 08:00:00 CEST | Press release

Employee-led recognition places Boomi among the UK's top medium-sized employers, with a flight risk of just 3% against a technology sector average of 42% Boomi achieves an average employee happiness score of 86%, rated Excellent across all six dimensions of WorkL's workplace framework Flight risk of just 3%, compared to a technology sector average of 42%, reflecting exceptional levels of employee loyalty Rated Excellent for Diversity and Inclusion and Confidence in Management Boomi, the data activation company for AI, has today been named one of The Sunday Times Best Places to Work 2026 in the Medium Organisation category. The prestigious annual list, produced by The Sunday Times in partnership with global workplace analytics company WorkL, recognises the UK's finest employers based entirely on direct employee feedback, making it one of the most credible and transparent employer benchmarks in the country. This press release features multimedia. View the full release here: https://www.b

LTM Has Issued an Offer to Acquire Randstad’s Technology and Consulting Services Business in Europe and Australia to Scale Domain-Driven Solutions and AI Services22.5.2026 07:09:00 CEST | Press release

The deal would be part of a 360° partnership with Randstad involving: Proposed acquisition of USD 500M+ (€469M) business, primarily across Aerospace & Defence, Automotive, Utilities and BFS Five-year IT services partnership to drive AI-enabled transformation for Randstad’s India Global Capability Center Strategic talent MSP to support LTM’s expanding global workforce LTM and Randstad announced that LTM has issued an offer to acquire Randstad’s Technology and Consulting Servicesbusiness in France, Germany, Belgium, Luxembourg and Australia, representing USD 500+ million (€469M) in annual revenue, to scale domain-driven solutions and AI services in the region. The proposed acquisition would expand LTM’s presence in key markets, primarily across Aerospace & Defence, Automotive, Utilities and BFS. It would enable local domain expertise and complementary regional capabilities in domain-driven digital engineering, cybersecurity and IoT, supported by onshore and nearshore delivery through cen

Polpharma Biologics and Tuteur Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases22.5.2026 07:00:00 CEST | Press release

Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, today announced the signing of a landmark licensing agreement with Argentina-based Tuteur. Under this strategic partnership, Tuteur will obtain exclusive rights to commercialize a biosimilar for autoimmune diseases across Latin America (LATAM), excluding Brazil. Polpharma Biologics will retain full responsibility for the development and manufacturing of the biosimilar. Tuteur will be responsible for commercialization, marketing, and distribution in the licensed territories. This collaboration reflects a shared commitment to expanding patient access to high-quality, affordable biological therapies across the region. “Partnering with Tuteur represents an important step in advancing our mission to broaden access to biosimilars globally,” said Anjan Selz, CEO of Polpharma Biologics. “With their strong regional expertise and commercial capabilities in LATAM, we are well

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye